
Sign up to save your podcasts
Or
Rubina Mulchandani is a graduate in Life Sciences and post graduate in Clinical Research, currently a PhD scholar in Clinical Research at the Indian Institute of Public Health, Public Health Foundation of India. Her research area is interdisciplinary and combines the fields of cardiovascular epidemiology and pharmacovigilance. Rubina is actively involved in teaching post graduate students and health professionals in the ongoing academic programmes and short-term training at the institute.
Cardiovascular diseases (CVDs) are responsible for a third of all global deaths a majority of which occur due to heart attacks and stroke. About 80% of these deaths occur in the developing countries, with mortality being the highest for the low- middle income countries.
Rubina’s research includes establishing a cohort to assess the neuro-cognitive changes among statin users over time. This is a longitudinal study where adults prescribed statins for dyslipidaemia in the last 1 year have been recruited from the Cardiology Out Patient Department of the study hospital. Her study hopes to add to the knowledge pool for this under-researched area of study in Asians, hopefully shedding light on the statin safety profile. This could help generate new hypotheses and provide a leeway for larger studies, with the ultimate aim of enhancing patient care. Please follow Rubina’s interesting work on Twitter @Rubina_BigB_EF
Rubina Mulchandani is a graduate in Life Sciences and post graduate in Clinical Research, currently a PhD scholar in Clinical Research at the Indian Institute of Public Health, Public Health Foundation of India. Her research area is interdisciplinary and combines the fields of cardiovascular epidemiology and pharmacovigilance. Rubina is actively involved in teaching post graduate students and health professionals in the ongoing academic programmes and short-term training at the institute.
Cardiovascular diseases (CVDs) are responsible for a third of all global deaths a majority of which occur due to heart attacks and stroke. About 80% of these deaths occur in the developing countries, with mortality being the highest for the low- middle income countries.
Rubina’s research includes establishing a cohort to assess the neuro-cognitive changes among statin users over time. This is a longitudinal study where adults prescribed statins for dyslipidaemia in the last 1 year have been recruited from the Cardiology Out Patient Department of the study hospital. Her study hopes to add to the knowledge pool for this under-researched area of study in Asians, hopefully shedding light on the statin safety profile. This could help generate new hypotheses and provide a leeway for larger studies, with the ultimate aim of enhancing patient care. Please follow Rubina’s interesting work on Twitter @Rubina_BigB_EF